BGM [BGM] vs Zoetis [ZTS] Detailed Stock Comparison
BGM
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: BGM wins in 6 metrics, Zoetis wins in 10 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | BGM | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.00 | 25.36 | BGM |
| Price-to-Book Ratio | 4.06 | 13.14 | BGM |
| Debt-to-Equity Ratio | 0.22 | 137.01 | BGM |
| PEG Ratio | N/A | 23.24 | N/A |
| EV/EBITDA | -29.15 | 17.91 | BGM |
| Profit Margin (TTM) | -26.32% | 27.83% | Zoetis |
| Operating Margin (TTM) | -5.41% | 40.20% | Zoetis |
| EBITDA Margin (TTM) | N/A | 40.20% | N/A |
| Return on Equity | -16.52% | 52.77% | Zoetis |
| Return on Assets (TTM) | -3.84% | 15.37% | Zoetis |
| Free Cash Flow (TTM) | $-3.39M | $2.30B | Zoetis |
| Dividend Yield | N/A | 1.11% | N/A |
| 1-Year Return | 33.68% | -16.11% | BGM |
| Price-to-Sales Ratio (TTM) | 50.51 | 6.96 | Zoetis |
| Enterprise Value | $69.18M | $70.67B | Zoetis |
| EV/Revenue Ratio | 2.32 | 7.53 | BGM |
| Gross Profit Margin (TTM) | N/A | 73.62% | N/A |
| Revenue per Share (TTM) | $4 | $21 | Zoetis |
| Earnings per Share (Diluted) | $-0.29 | $5.81 | Zoetis |
| Beta (Stock Volatility) | 1.46 | 0.88 | Zoetis |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
BGM vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| BGM | 6.65% | 5.94% | -20.12% | -37.54% | -19.64% | -10.29% |
| Zoetis | 1.51% | 4.59% | 0.82% | -3.89% | -1.51% | -5.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| BGM | 33.68% | 29.26% | -82.13% | -82.13% | -82.13% | -82.13% |
| Zoetis | -16.11% | -9.09% | -2.69% | 242.31% | 396.97% | 396.97% |
Performance & Financial Health Analysis: BGM vs Zoetis
| Metric | BGM | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $1.51B | $65.30B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 31,820 | 4,111,510 |
| 90 Day Avg. Volume | 76,630 | 3,459,870 |
| Last Close | $8.02 | $167.10 |
| 52 Week Range | $5.47 - $17.17 | $139.70 - $200.33 |
| % from 52W High | -53.29% | -16.59% |
| All-Time High | $110.00 (Jan 11, 2021) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -92.71% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.57% | 0.04% |
| Quarterly Earnings Growth | -0.16% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.26% | 0.28% |
| Operating Margin (TTM) | -0.05% | 0.40% |
| Return on Equity (TTM) | -0.17% | 0.53% |
| Debt to Equity (MRQ) | 0.22 | 137.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.85 | $11.21 |
| Cash per Share (MRQ) | $3.55 | $3.28 |
| Operating Cash Flow (TTM) | $2.96M | $2.93B |
| Levered Free Cash Flow (TTM) | $3.36M | $2.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.11% |
| Last 12-Month Dividend | $0.00 | $1.86 |
Valuation & Enterprise Metrics Analysis: BGM vs Zoetis
| Metric | BGM | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.00 | 25.36 |
| Forward P/E | N/A | 23.24 |
| PEG Ratio | N/A | 23.24 |
| Price to Sales (TTM) | 50.51 | 6.96 |
| Price to Book (MRQ) | 4.06 | 13.14 |
| Market Capitalization | ||
| Market Capitalization | $1.51B | $65.30B |
| Enterprise Value | $69.18M | $70.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.32 | 7.53 |
| Enterprise to EBITDA | -29.15 | 17.91 |
| Risk & Other Metrics | ||
| Beta | 1.46 | 0.88 |
| Book Value per Share (MRQ) | $1.85 | $11.21 |
Financial Statements Comparison: BGM vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BGM | ZTS |
|---|---|---|
| Revenue/Sales | N/A | $2.22B |
| Cost of Goods Sold | N/A | $622.00M |
| Gross Profit | N/A | $1.60B |
| Research & Development | N/A | $157.00M |
| Operating Income (EBIT) | N/A | $846.00M |
| EBITDA | N/A | $991.00M |
| Pre-Tax Income | N/A | $810.00M |
| Income Tax | N/A | $179.00M |
| Net Income (Profit) | N/A | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BGM | ZTS |
|---|---|---|
| Cash & Equivalents | $9.82M | $1.72B |
| Total Current Assets | $29.77M | $5.88B |
| Total Current Liabilities | $8.78M | $3.39B |
| Long-Term Debt | $0 | $5.40B |
| Total Shareholders Equity | $44.09M | $4.66B |
| Retained Earnings | $4.35M | $12.38B |
| Property, Plant & Equipment | $0 | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BGM | ZTS |
|---|---|---|
| Operating Cash Flow | N/A | $567.00M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $438.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | BGM | ZTS |
|---|---|---|
| Shares Short | 7,202 | 7.85M |
| Short Ratio | 0.17 | 2.67 |
| Short % of Float | 0.00% | 0.02% |
| Average Daily Volume (10 Day) | 31,820 | 4,111,510 |
| Average Daily Volume (90 Day) | 76,630 | 3,459,870 |
| Shares Outstanding | 7.15M | 448.47M |
| Float Shares | 2.83M | 442.37M |
| % Held by Insiders | 0.07% | 0.00% |
| % Held by Institutions | 0.00% | 0.98% |
Dividend Analysis & Yield Comparison: BGM vs Zoetis
| Metric | BGM | ZTS |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $1.86 |
| Last 12-Month Dividend Yield | N/A | 1.11% |
| 3-Year Avg Annual Dividend | $0.08 | $1.63 |
| 3-Year Avg Dividend Yield | 3.70% | 0.24% |
| 3-Year Total Dividends | $0.25 | $4.90 |
| Ex-Dividend Date | Feb 27, 2023 | Apr 21, 2025 |